Our Pipeline

TB Alliance works with a diverse network of global partners, including the world’s leading pharmaceutical developers, academic institutions, and research institutes. The following organizations are TB Alliance research and development partners.

AbbVie

AIDS Clinical Trial Group (ACTG)

Bill & Melinda Gates Foundation

Bill & Melinda Gates Medical Research Institute

ERA4TB

Evotec

Foundation for Neglected Disease Research

GlaxoSmithKline

Global Health Drug Discovery Institute

Harvard University

Hongqi Pharmaceutical

IMPAACT

Institute of Materia Medica

International Tuberculosis Research Center (ITRC)

Janssen Pharmaceuticals

Johns Hopkins University

KNCV Tuberculosefonds

Korea International Cooperation Agency (KOICA)

Lgenia

Lupin

Macleods

Médecins Sans Frontières (MSF) Amsterdam Office

Medical Research Council at University College London

National Center for Advancing Translational Sciences (NCATS)

Otsuka Pharmaceutical

PanACEA

Qurient Therapeutics

Radboud University

Schrodinger

TB Drug Accelerator Program

Texas A&M University

The Aurum Institute

UNITE4TB Consortium

University College London

University of Auckland

University of Illinois at Chicago

University of North Carolina

University of St. Andrews

Viatris

Weill Cornel Medical